Table 2.
Treatment response to conversion therapy based on mRECIST and RECIST1.1.
Overall response | mRECIST (n=94) | RECIST1.1 (n=94) |
---|---|---|
Complete response | 13 (13.8%) | 0 |
Partial response | 69 (73.4%) | 25 (26.6%) |
Stable disease | 6 (6.4%) | 63 (67.0%) |
Progressive disease | 6 (6.4%) | 6 (6.4%) |
Overall response rate | 82 (87.2%) | 25 (26.6%) |
Disease control rate | 88 (93.6%) | 88 (93.6%) |